Annals of Nuclear Medicine

Papers
(The TQCC of Annals of Nuclear Medicine is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Assessing dedicated breast PET performance in breast cancer screening alongside digital mammography, digital breast tomosynthesis, and ultrasound: a reader's insight116
Only peak thyroglobulin concentration on day 1 and 3 of rhTSH-aided RAI adjuvant treatment has prognostic implications in differentiated thyroid cancer78
Conversion from dose length product to effective dose for the CT component of whole-body PET/CT46
Coronary plaque instability assessed by positron emission tomography and optical coherence tomography41
Optimization of injection dose in 18F-FDG PET/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan38
Correction: Novel indices representing heterogeneous distributions of myocardial perfusion imaging29
A first-in-man study of [18F] FEDAC: a novel PET tracer for the 18-kDa translocator protein28
18F-FET PET/CT can aid in diagnosing patients with indeterminate MRI findings for brain tumors: a prospective study28
[18F]FDG PET/CT is useful in discriminating invasive adenocarcinomas among pure ground-glass nodules: comparison with CT findings—a bicenter retrospective study27
Highly specific amyloid and tau PET ligands for ATN classification in suspected Alzheimer’s disease patients26
FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer?25
Research trends and hotspots of radioiodine-refractory thyroid cancer treatment in the twenty-first century: a bibliometric analysis20
Measuring myocardial blood flow with 82rubidium using Gjedde–Patlak–Rutland graphical analysis20
Semiquantitative analysis using whole-body dynamic F-18 fluoro-2-deoxy-glucose–positron emission tomography to differentiate between benign and malignant lesions19
Comparison of the diagnostic accuracy of VSBONE BSI versions for detecting bone metastases in breast and prostate carcinoma patients using conventional and CZT detector gamma cameras19
The value of 18F-FDG PET/CT in Langerhans cell histiocytosis18
Impact of irregular waveforms on data-driven respiratory gated PET/CT images processed using MotionFree algorithm16
Efficacy of [68Ga]Ga-FAPI-PET as a non-invasive evaluation method of liver fibrosis16
J-ACCESS investigation and nuclear cardiology in Japan: implications for heart failure15
Correction: Practice recommendation for measuring washout rates in 123I-BMIPP fatty acid images15
Methyl-11C-L-methionine positron emission tomography for radiotherapy planning for recurrent malignant glioma15
Correction: Clinical assessment and striatal dopaminergic activity in healthy controls and patients with Parkinson’s disease: a Bayesian approach15
Increase of prostate-specific antigen doubling time predicts survival in metastatic castration-resistant prostate cancer patients undergoing radium therapy15
A fully automatic deep learning-based method for segmenting regions of interest and predicting renal function in pediatric dynamic renal scintigraphy14
Progress and future prospective of FDG-PET/CT imaging combined with optimized procedures in lung cancer: toward precision medicine14
Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT14
Incidence of renal scarring on technetium-99 m dimercaptosuccinic acid renal scintigraphy after acute pyelonephritis, acute focal bacterial nephritis, and renal abscess14
Simultaneous evaluation of brain metastasis and thoracic cancer using semiconductor 11C-methionine PET/CT imaging13
Comparison of transient and permanent LAD ligation in mice using 18F-FDG PET imaging13
Flare phenomenon visualized by 99mTc-bone scintigraphy has prognostic value for patients with metastatic castration-resistant prostate cancer13
Increased individual workload for nuclear medicine physicians over the past years: 2008–2023 data from The Netherlands13
Left-ventricular dyssynchrony in viable myocardium by myocardial perfusion SPECT is predictive of mechanical response to CRT13
Novel indices representing heterogeneous distributions of myocardial perfusion imaging12
Feasibility of whole-body 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography angiography using continuous bed motion in patients with vascular disease: a pilot study12
Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism12
Prediction of multivessel coronary artery disease and candidates for stress-only imaging using multivariable models with myocardial perfusion imaging12
Radiosynovectomy is effective in thumb basal joint arthritis12
Recent advancements in new tracers from first-in-human studies11
Texture analysis of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography for predicting the treatment response of postoperative recurrent or metastatic oral squamous cell carcinom11
Insights into lung cancer diagnosis and clinical management using [18F]F-fibroblast activation protein inhibitor (FAPI)-42 positron emission tomography/computed tomography (PET/CT)11
Can interactive artificial intelligence be used for patient explanations of nuclear medicine examinations in Japanese?11
Factors predicting remission in hyperthyroid patients after low-dose I-131 therapy: 20 years retrospective study from a tertiary care hospital11
[18F]FEDAC translocator protein positron emission tomography–computed tomography for early detection of mitochondrial dysfunction secondary to myocardial ischemia11
Improvement in the estimation of perfusable tissue fraction and myocardial flow reserve in the ischemic myocardial lesions using ECG-gated dynamic myocardial PET with 15O-water11
Is there any effect of hcc location on selective internal radiation therapy with 90yttrium response?10
Correction to: Generative image transformer (GIT): unsupervised continuous image generative and transformable model for [123I]FP-CIT SPECT images10
Impact of preoperative [18F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study10
Differential centiloid scale normalization techniques: comparison between hybrid PET/MRI and independently acquired MRI10
Correction: Diagnostic utility and characteristics of CT-based attenuation correction in brain perfusion SPECT/CT in predicting the exacerbation of Alzheimer changes from mild cognitive impairment uti10
Current status and perspectives of nuclear cardiology10
Multimodal imaging analysis of autosomal recessive Parkinson’s disease10
Detection of apoptosis by [18F]ML-10 after cardiac ischemia–reperfusion injury in mice10
Superiority of 68Ga-PSMA-11 PET/CT over mpMRI for lateralization accuracy of diagnosing intra-glandular prostate cancer lesions: avoiding fluke targeting9
Usefulness of albumin–globulin ratio as a clinical prognostic factor in patients with thyroid cancer treated with radioiodine9
Prognostic value of textural features obtained from F-fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) in patients with locally advanced cervical cancer undergoi9
Brain imaging of sequential acquisition using a flexible PET scanner and 3-T MRI: quantitative and qualitative assessment9
Temporal metabolic response and mRNA COVID-19 vaccination9
Performance evaluation of dedicated brain PET scanner with motion correction system9
18F-FDG cerebellum/liver index as a prognostic factor for progression-free survival in diffuse large B-cell lymphoma9
[99mTc]-labeling and evaluation of a new linear peptide for imaging of glioblastoma as a αvβ3-positive tumor9
Usefulness of 18F-FDG PET/CT in treatment-naive patients with thymic squamous cell carcinoma9
Diagnostic performance of F-18 FDG PET/CT in differentiating autoimmune pancreatitis from pancreatic cancer: a systemic review and meta-analysis9
A Monte Carlo study comparing dead-time losses of a gamma camera between tungsten functional paper and lead sheet for dosimetry in targeted radionuclide therapy with Lu-1779
High efficacy of particle beam therapies against tumors under hypoxia and prediction of the early stage treatment effect using 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography9
Booster administration of Tc-99m PMT for delayed static imaging in patients with biliary atresia8
Assessment of post-pyeloplasty renal drainage in antenatally detected hydronephrosis by 99mTc-L, L-Ethylenedicysteine renal scintigraphy: the importance of delayed imaging8
Correlation of 68Ga-DOTATATE uptake on PET/CT with pathologic features of cellular proliferation in neuroendocrine neoplasms8
New objective simple evaluation methods of amyloid PET/CT using whole-brain histogram and Top20%-Map8
Fundamental evaluation regarding the relationship between albumin-binding and tumor accumulation of PSMA-targeting radioligands8
Correction to: Detection efficacy of PET/CT with 18F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study8
Next day sentinel node biopsy for melanoma after lymphoscintigraphy using 99mTc-labelled nanocolloid does not adversely affect long-term outcomes8
Feasibility of position emission tomography derived endocardial wall strain: direct comparison with magnetic resonance using hybrid 13N ammonia PETMR system8
The value of net influx constant based on FDG PET/CT dynamic imaging in the differential diagnosis of metastatic from non-metastatic lymph nodes in lung cancer8
Validation of advanced hybrid SPECT/CT system using dynamic anthropomorphic cardiac phantom8
Recent topics in fibroblast activation protein inhibitor-PET/CT: clinical and pharmacological aspects8
Manual on the proper use of meta-[211At] astato-benzylguanidine ([211At] MABG) injections in clinical trials for targeted alpha therapy (1st edition)8
99mTc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients8
Convolutional neural network-based program to predict lymph node metastasis of non-small cell lung cancer using 18F-FDG PET7
Physiological bio-distribution of 68Ga-DOTA-TATE in pediatric patients7
Artificial neural network for the prediction model of glomerular filtration rate to estimate the normal or abnormal stages of kidney using gamma camera7
Effects of apitherapy against salivary gland disorder after radioactive iodine therapy for differentiated thyroid cancer7
Comparative evaluation of radionuclide therapy using 90Y and 177Lu7
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma7
Clinical value of 18F-FDG PET/CT in IgG4-related disease7
Measurement of changes in endogenous serotonin level by positron emission tomography with [18F]altanserin7
Prognostic value of FDG PET-CT in suspected recurrence of colorectal carcinoma: survival outcomes of a 10-year follow-up7
Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients7
Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects7
Blood and bone marrow dosimetry for thyroid cancer patients prepared with rhTSH injection7
Inferences of SPECT renal dynamic imaging injection quality based on lung and abdominal aorta imaging features7
A prospective study of 68Ga-PSMA PET/CT imaging of HCC as diagnosed on conventional imaging to evaluate for potential 177Lu-PSMA therapy6
Application of artificial intelligence in brain molecular imaging6
99mTc-labeled peptide targeting interleukin 13 receptor α 2 for tumor imaging in a cervical cancer mouse model6
First clinical assessment of [18F]MC225, a novel fluorine-18 labelled PET tracer for measuring functional P-glycoprotein at the blood–brain barrier6
Development of lung cancer risk prediction models based on F-18 FDG PET images6
Characterization of the benign lesions with increased 68Ga-FAPI-04 uptake in PET/CT6
The quest for multifunctional and dedicated PET instrumentation with irregular geometries6
Patient dosimetry of 177Lu-PSMA I&T in metastatic prostate cancer treatment: the experience in Thailand6
Comparison between dynamic whole-body FDG-PET and early-delayed imaging for the assessment of motion in focal uptake in colorectal area6
The role of Hashimoto thyroiditis in predicting radioiodine ablation efficacy and prognosis of low to intermediate risk differentiated thyroid cancer6
18F-FDG PET/CT as predictive and prognostic factor in esophageal cancer treated with combined modality treatment6
Advances in the molecular imaging of primary aldosteronism6
Investigation on low-iodine diet implementation by medical staff before radioactive iodine treatment for differentiated thyroid carcinoma6
Evaluation of 68Ga-PSMA-11 PET/CT: a Phase 1 clinical study in Japanese patients with primary, recurrent, or suspected recurrent prostate cancer5
SPECT/CT imaging: quantifying 99mTc-MDP concentration in the spine and pelvis5
Detection efficacy of PET/CT with 18F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study5
Performance of dedicated breast PET in breast cancer screening: comparison with digital mammography plus digital breast tomosynthesis and ultrasound5
Radiolabeled florescent-magnetic graphene oxide nanosheets: probing the biodistribution of a potential PET-MRI hybrid imaging agent for detection of fibrosarcoma tumor5
Comparative post-therapeutic dosimetry between 2D planar-based and hybrid-based methods for personalized Lu-177 treatment5
Validation of quantitative [18F]NaF PET uptake parameters in bone diseases: a systematic review5
Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment5
Toward standardization of tau PET imaging corresponding to various tau PET tracers: a multicenter phantom study5
Differentiating second primary lung cancer from pulmonary metastasis in patients of single solitary pulmonary lesion with extrapulmonary tumor using multiparametric analysis of FDG PET/CT5
Predictive value of multiple metabolic and heterogeneity parameters of 18F-FDG PET/CT for EGFR mutations in non-small cell lung cancer5
Correlation between the thyroid computed tomography value and thyroid function in hyperthyroidism: a retrospective study5
New index to assess the extent of bone disease in patients with prostate cancer using SPECT/CT5
68Ga-DOTA-FAPI-04 PET/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients5
Use of dose–volume histograms for metabolic response prediction in hepatocellular carcinoma patients undergoing transarterial radioembolization with Y-90 resin microspheres5
Clinicopathological variables that correlate with sestamibi positivity in uniglandular parathyroid disease: a retrospective analysis of 378 parathyroid adenomas5
Prognostic value of 18F-FDG PET/CT with texture analysis in patients with rectal cancer treated by surgery5
Role of PSMA-targeted PET-CT in renal cell carcinoma: a systematic review and meta-analysis5
Diagnostic performance of noninvasive imaging using computed tomography, magnetic resonance imaging, and positron emission tomography for the detection of ovarian cancer: a meta-analysis5
Pre-treatment 111In-pentetreotide SPECT/CT vs. baseline 177Lu-DOTATATE SPECT/CT: are there differences in lesion uptake and detectability?5
0.13013505935669